Please Wait.....
Report
Neurology Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
Market Report I 2025-05-19 I 165 Pages I Global Market Insights
The Global Neurology Devices Market was valued at USD 14.3 billion in 2024 and is estimated to grow at a CAGR of 7.2% to reach USD 28.3 billion by 2034, fueled by a combination of technological innovation, rising rates of neurological conditions, increased healthcare spending, and improved access to medical services. Developments in AI-powered remote monitoring and brain-computer interface systems have significantly improved patient care outcomes. In addition, emerging minimally invasive neurotechnologies-such as portable EEG monitors and enhanced stimulation systems-are transforming neurological treatment and diagnosis. These advances have made it possible to deliver more precise, safer, and efficient therapeutic interventions, contributing to the overall expansion of the neurology devices sector. Neurology devices include implantable tools, surgical instruments, and diagnostic technologies used to manage conditions affecting the nervous system, such as the brain, spine, and peripheral nerves.
Neurology devices include implantable tools, surgical instruments, and diagnostic technologies used to manage conditions affecting the nervous system, such as the brain, spine, and peripheral nerves. These devices are designed to aid in the detection, monitoring, treatment, and rehabilitation of neurological disorders, including epilepsy, Parkinson's disease, Alzheimer's disease, multiple sclerosis, brain tumors, and traumatic brain injuries. They serve a critical role across a range of clinical settings, from routine neurological assessments to complex neurosurgical procedures. Diagnostic tools such as EEG systems and neuroimaging technologies help in the early and accurate identification of neurological conditions, while implantable devices like neurostimulators offer long-term therapeutic benefits for patients suffering from chronic and progressive diseases.
Among the main categories, the neurostimulation devices segment generated USD 7 billion in 2024. These include systems like spinal cord stimulators and vagus nerve stimulators, designed to address movement disorders, chronic pain, psychiatric issues, and epilepsy. Newer models, such as closed-loop systems, MRI-compatible implants, and miniaturized solutions, have improved patient outcomes and broadened therapeutic applications, reinforcing growth in this segment.
By end use, hospitals led the market in 2024 with a dominant share of 56.1%, driven by their comprehensive infrastructure and ability to handle complex neurological cases. Hospitals conduct a majority of diagnostic and therapeutic procedures, making them key hubs for the adoption of neuroimaging and neuromodulation systems. Their role in managing emergency neurological events such as seizures, strokes, and traumatic injuries ensures constant demand for cutting-edge equipment.
United States Neurology Devices Market was valued at USD 5.2 billion in 2024, supported by increasing neurological disease prevalence, robust clinical research infrastructure, and substantial government funding. Major federal initiatives and research grants continue to back advancements in neuroprosthetics and brain-computer interface systems. A growing elderly population and a shortage of specialized neurology professionals are also pushing greater reliance on advanced devices to meet the rising demand for care.
Key players actively shaping The Neurology Devices Industry landscape include Synchron, B BRAUN, LivaNova, NeuroPace, ZYLOX TONBRIDGE, Abbott Laboratories, MicroTransponder, KARL STROZ, Medtronic, stryker, Bioness, nevro, Boston Scientific, Enterra Medical, and Paradromics. To strengthen their position in the neurology devices market, leading companies are focusing on research-driven product innovation and the development of AI-integrated systems. These firms are expanding their portfolios with minimally invasive devices and patient-specific solutions that enhance safety and precision. Strategic partnerships, regulatory approvals, and increased investments in neurotechnology R&D are also central to their approach. Businesses are refining device compatibility with imaging systems and pursuing compact, portable formats for broader clinical use. Additionally, major players are scaling up manufacturing capabilities and entering into global collaborations to secure contracts, boost geographic presence, and align with healthcare systems aiming for smarter neurological care delivery.
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of neurological disorders
3.2.1.2 Growing adoption of minimally invasive procedure
3.2.1.3 Technological advancements
3.2.1.4 Increased funding and investments
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of devices and procedures
3.2.2.2 Risk of device failure and complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technology landscape
3.6 Trump administration tariffs
3.6.1 Impact on trade
3.6.1.1 Trade volume disruptions
3.6.1.2 Retaliatory measures
3.6.2 Impact on the Industry
3.6.2.1 Supply-side impact (raw materials)
3.6.2.1.1 Price volatility in key materials
3.6.2.1.2 Supply chain restructuring
3.6.2.1.3 Production cost implications
3.6.2.2 Demand-side impact (selling price)
3.6.2.2.1 Price transmission to end markets
3.6.2.2.2 Market share dynamics
3.6.2.2.3 Consumer response patterns
3.6.3 Key companies impacted
3.6.4 Strategic industry responses
3.6.4.1 Supply chain reconfiguration
3.6.4.2 Pricing and product strategies
3.6.4.3 Policy engagement
3.6.5 Outlook and future considerations
3.7 Reimbursement scenario
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Gap analysis
3.11 Future market trends
3.12 Value chain analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Device, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Neurostimulation devices
5.2.1 Spinal cord stimulators
5.2.2 Deep brain stimulators
5.2.3 Vagus nerve stimulators
5.2.4 Sacral nerve stimulators
5.2.5 Gastric electrical stimulators
5.3 Neurosurgical devices
5.3.1 Stereotactic systems
5.3.2 Neuroendoscopes
5.3.3 Ultrasonic aspirators
5.3.4 Aneurysm clips
5.4 Interventional neurology devices
5.4.1 Aneurysm coiling and embolisation
5.4.1.1 Embolic coils
5.4.1.2 Flow diversion devices
5.4.1.3 Liquid embolic reagents
5.4.2 Neurothromobectomy
5.4.2.1 Clot retrievers
5.4.2.2 Suction aspiration devices
5.4.2.3 Snare devices
5.4.3 Neurovascular catheters
5.4.3.1 Micro catheters
5.4.3.2 Micro guidewires
5.4.4 Cerebral balloon angioplasty andstents
5.4.4.1 Carotid artery stents
5.4.4.2 Filter devices
5.4.4.3 Balloon occlusion devices
5.4.5 Csf management devices
5.4.5.1 Cerebral shunts
5.4.5.2 Cerebral external drainage
5.5 Brain-computer interface devices
5.5.1 Non-invasive BCI
5.5.2 Partially invasive BCI
5.5.3 Fully invasive BCI
5.6 Other devices
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Chronic pain management
6.3 Parkinson's disease
6.4 Epilepsy
6.5 Stroke management and recovery
6.6 Alzheimer
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Other end use
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 B BRAUN
9.3 Bioness
9.4 Boston Scietific
9.5 enterra medical
9.6 KARL STROZ
9.7 LivaNova
9.8 Medtronic
9.9 MicroTransponder
9.10 NeuroPace
9.11 nevro
9.12 Paradromics
9.13 stryker
9.14 synchron
9.15 ZYLOX TONBRIDGE
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security